Physician profile
Lorraine Cornwell
NPI 1447241633
$6,610.33
in general payments reported to CMS, 2019-2025
15 companies · $72.15 in 2025
The $72.15 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,953 · 2020: $120 · 2021: $660 · 2022: $608 · 2023: $2,137 · 2024: $1,060 · 2025: $72.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,348 · Travel and Lodging: $920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,348.38 |
| Travel and Lodging | $920.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,987.10 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve |
| Atricure, INC. | $1,010.17 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Angiodynamics, INC. | $938.77 | 2020-2024 | Angiovac |
| Medtronic Vascular, INC. | $349.69 | 2019 | |
| Abiomed | $332.90 | 2022-2025 | |
| Intuitive Surgical, INC. | $263.01 | 2019-2022 | |
| Inari Medical, INC. | $238.80 | 2021 | |
| Medtronic, INC. | $126.23 | 2022-2023 | Corevalve Evolut R |
| Zimmer Biomet Holdings, INC. | $104.27 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $92.19 | 2024 | |
| Lumendi LLC | $51.61 | 2019 | |
| Smith+Nephew, INC. | $41.58 | 2019-2020 | |
| Artivion, INC. | $36.78 | 2019 | |
| Medinc of Texas | $23.83 | 2025 | |
| Clearflow INC. | $13.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorraine Cornwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.